Tommy Rampling

13.4k total citations · 1 hit paper
28 papers, 706 citations indexed

About

Tommy Rampling is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Tommy Rampling has authored 28 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 10 papers in Public Health, Environmental and Occupational Health and 8 papers in Molecular Biology. Recurrent topics in Tommy Rampling's work include Bacillus and Francisella bacterial research (7 papers), Poxvirus research and outbreaks (7 papers) and Mosquito-borne diseases and control (6 papers). Tommy Rampling is often cited by papers focused on Bacillus and Francisella bacterial research (7 papers), Poxvirus research and outbreaks (7 papers) and Mosquito-borne diseases and control (6 papers). Tommy Rampling collaborates with scholars based in United Kingdom, United States and South Africa. Tommy Rampling's co-authors include Catherine Houlihan, Hannah M. Rickman, Karen Shaw, Pietro G. Coen, Maryam Shahmanesh, Eleni Nastouli, Gee Yen Shin, Katie Ewer, Adrian V. S. Hill and Susan Gould and has published in prestigious journals such as Clinical Infectious Diseases, Frontiers in Immunology and European Respiratory Journal.

In The Last Decade

Tommy Rampling

24 papers receiving 697 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Family cluster of three cases of monkeypox imported from Nigeria to the United Kingdom, May 2021

2021 144 citations Gemma Hobson, James P. Adamson et al. Eurosurveillance profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tommy Rampling United Kingdom	11	230	185	163	162	150	28	706
Claire M. Midgley United States	13	522 2.3×	271 1.5×	244 1.5×	189 1.2×	169 1.1×	26	938
Krutika Kuppalli United States	9	530 2.3×	177 1.0×	196 1.2×	59 0.4×	108 0.7×	16	825
Daniel Mukadi‐Bamuleka Democratic Republic of the Congo	7	928 4.0×	235 1.3×	122 0.7×	153 0.9×	222 1.5×	24	1.2k
Lewis McCurdy United States	16	456 2.0×	465 2.5×	100 0.6×	324 2.0×	166 1.1×	38	1.0k
Praveen Dhankhar United States	10	223 1.0×	433 2.3×	113 0.7×	277 1.7×	159 1.1×	18	859
Jorge Villacian Singapore	14	495 2.2×	210 1.1×	52 0.3×	286 1.8×	86 0.6×	21	800
Susanne H. Hodgson United Kingdom	14	423 1.8×	93 0.5×	190 1.2×	34 0.2×	98 0.7×	24	864
Simon P. Jochems Netherlands	14	170 0.7×	231 1.2×	50 0.3×	103 0.6×	76 0.5×	37	640
Mohamed Fawzy Egypt	11	389 1.7×	88 0.5×	56 0.3×	38 0.2×	110 0.7×	33	727
Mohana Kunasekaran Australia	12	118 0.5×	131 0.7×	43 0.3×	79 0.5×	70 0.5×	52	421

Countries citing papers authored by Tommy Rampling

Since Specialization

Citations

This map shows the geographic impact of Tommy Rampling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tommy Rampling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tommy Rampling more than expected).

Fields of papers citing papers by Tommy Rampling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tommy Rampling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tommy Rampling. The network helps show where Tommy Rampling may publish in the future.

Co-authorship network of co-authors of Tommy Rampling

This figure shows the co-authorship network connecting the top 25 collaborators of Tommy Rampling. A scholar is included among the top collaborators of Tommy Rampling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tommy Rampling. Tommy Rampling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jones, Scott, Bethany Hicks, D. R. C. Bailey, et al.. (2025). Assessment of MpoxPlex, a high-throughput and multiplexed immunoassay: a diagnostic accuracy study. The Lancet Microbe. 6(4). 100987–100987. 4 indexed citations

Warrell, Clare E., Tommy Rampling, Dipti Patel, et al.. (2025). Sofosbuvir as post-exposure prophylaxis for yellow fever–associated viscerotropic disease (YEL-AVD). Journal of Antimicrobial Chemotherapy. 80(3). 825–827. 1 indexed citations

Beard, Kate, Jane Osborne, Kevin Brown, et al.. (2025). Tick-borne encephalitis: from tick surveillance to the first confirmed human cases, the United Kingdom, 2015 to 2023. Eurosurveillance. 30(5). 3 indexed citations

Hicks, Bethany, Scott Jones, D. R. C. Bailey, et al.. (2024). Evaluation of a multiplexed immunoassay for assessing long-term humoral immunity Orthopoxviruses. Vaccine. 42(26). 126453–126453. 2 indexed citations

Thompson, Ameeka, Tim Brooks, Catherine Houlihan, et al.. (2024). Investigation of a Human Case of Francisella tularensis Infection, United Kingdom, 2023. Emerging infectious diseases. 30(10). 2188–2190.

Warrell, Clare E., Zain Chaudhry, Hannah Rafferty, et al.. (2024). A Cross-Sectional Evaluation of the Virtual Outpatient Management of People With Mpox. Open Forum Infectious Diseases. 11(8). ofae413–ofae413. 1 indexed citations

Fifer, Helen, Ashley Otter, Rachel Pitt, et al.. (2023). P031 Prevalence of Mpox-specific antibodies in sera collected between January – September 2022 in England. A cross-sectional seroprevalence study. A38.1–A38.

Warrell, Clare E., Jane Osborne, Laura Nabarro, et al.. (2023). Imported rickettsial infections to the United Kingdom, 2015–2020. Journal of Infection. 86(5). 446–452. 7 indexed citations

Killip, Marian J., et al.. (2023). Monkeypox virus isolation from longitudinal samples from four patients to infer risk of onwards transmission: an interim analysis. Journal of Hospital Infection. 135. 139–144. 5 indexed citations

10.

Brown, Michael, Megan Plowright, Katie Drury, et al.. (2022). Demographics and Outcomes of Initial Phase of COVID-19 Medicines Delivery Units Across 4 UK Centers During Peak B1.1.529 Omicron Epidemic: A Service Evaluation. Open Forum Infectious Diseases. 9(10). ofac527–ofac527. 2 indexed citations

11.

Brown, Mike, Megan Plowright, Katie Drury, et al.. (2022). Demographics and Outcomes of COVID-19 Medicines Delivery Units Across 4 UK Centres During the Initial B1.1.529 Omicron Epidemic: A Service Evaluation.. SSRN Electronic Journal.

12.

Hobson, Gemma, James P. Adamson, Hugh Adler, et al.. (2021). Family cluster of three cases of monkeypox imported from Nigeria to the United Kingdom, May 2021. Eurosurveillance. 26(32). 144 indexed citations breakdown →

13.

Gupta, Rishi K, Michael Marks, Akish Luintel, et al.. (2020). Systematic evaluation and external validation of 22 prognostic models among hospitalised adults with COVID-19: an observational cohort study. European Respiratory Journal. 56(6). 2003498–2003498. 96 indexed citations

14.

Rampling, Tommy, Colin J. Sutherland, & C. W. M. Whitty. (2019). Imported malaria: key messages in an era of elimination. Clinical Medicine. 19(2). 153–156. 3 indexed citations

15.

Bowyer, Georgina, Tommy Rampling, Jonathan Powlson, et al.. (2018). Activation-induced Markers Detect Vaccine-Specific CD4+ T Cell Responses Not Measured by Assays Conventionally Used in Clinical Trials. Vaccines. 6(3). 50–50. 46 indexed citations

16.

Ewer, Katie, Christopher M. Smith, Georgina Bowyer, et al.. (2018). DURABILITY OF IMMUNE RESPONSES INDUCED BY THREE LEADING CANDIDATE EBOLA VACCINE REGIMES; RVSV ZEBOV, CHAD3 EBO Z-MVA BN-FILO AND ADHU26. ZEBOV-MVA BN FILO. American Journal of Tropical Medicine and Hygiene. 99. 214–215. 1 indexed citations

17.

Bowyer, Georgina, Tommy Rampling, Navin Venkatraman, et al.. (2018). CXCR3+ T Follicular Helper Cells Induced by Co-Administration of RTS,S/AS01B and Viral-Vectored Vaccines Are Associated With Reduced Immunogenicity and Efficacy Against Malaria. Frontiers in Immunology. 9. 1660–1660. 28 indexed citations

18.

Churcher, Thomas S., Nick J. Edwards, Ian Poulton, et al.. (2017). PROBABILITY OF TRANSMISSION OF MALARIA FROM MOSQUITO TO HUMAN IS REGULATED BY PARASITE DENSITY IN NAIVE AND VACCINATED HOSTS. American Journal of Tropical Medicine and Hygiene. 97. 230–230. 1 indexed citations

19.

Churcher, Thomas S., Robert E. Sinden, Nick J. Edwards, et al.. (2017). Probability of Transmission of Malaria from Mosquito to Human Is Regulated by Mosquito Parasite Density in Naïve and Vaccinated Hosts. PLoS Pathogens. 13(1). e1006108–e1006108. 79 indexed citations

20.

Rampling, Tommy. (2003). Quality of Life Measurement in the Head and Neck Cancer Radiotherapy Clinic: Is it Feasible and Worthwhile?. Clinical Oncology. 15(4). 205–210. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact